Erste Asset Management GmbH reduced its stake in Vertex Pharmaceuticals (NASDAQ:VRTX) by 8.6% in the third quarter, now holding 67,517 shares valued at $26.69 million. Other institutional investors have also adjusted their positions in the pharmaceutical company. Despite a slight EPS miss in Q4 earnings, analysts maintain a “Moderate Buy” rating for VRTX, with an average target price of $542.00, though significant insider selling was noted.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Erste Asset Management GmbH Has $26.69 Million Position in Vertex Pharmaceuticals Incorporated $VRTX
Erste Asset Management GmbH reduced its stake in Vertex Pharmaceuticals (NASDAQ:VRTX) by 8.6% in the third quarter, now holding 67,517 shares valued at $26.69 million. Other institutional investors have also adjusted their positions in the pharmaceutical company. Despite a slight EPS miss in Q4 earnings, analysts maintain a “Moderate Buy” rating for VRTX, with an average target price of $542.00, though significant insider selling was noted.